Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT05692778
Recruiting Observational

Optimized Care of People With Diabetes and Foot Complication in Primary Care

NCT05692778 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2020-01-01
Last updated
2024-04-17

Condition(s) studied

DiabetesDiabetic FootDiabetes MellitusDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Complications

Investigational drug(s) / intervention(s)

Patients being foot examined by using an eHealth toolPatients being foot examined in traditional manner

Patients being foot examined by using an eHealth tool: Patients being foot examined by using an eHealth tool that has been developed, will be tested with the intention to implement the eHealth tool

Patients being foot examined in traditional manner: Patient are being foot examined in the way as health care professionals usually make the foot examination in patients with diabetes

Study summary

The goal of this observational study is to create and evaluate and new management, by using eHealth tools, to prevent diabetic foot ulcers. The main questions it aims to answer are:

1. Validation

a. Is a method for foot assessment, that uses eHealth tools, valid regarding its usefulness? b. Is a method for foot assessment, that uses eHealth tools, reliable regarding the generated risk stratification?
2. Mapping

1. How do health care professionals and patients with diabetes experience that the future foot examination should be designed?
2. What experiences have health care professionals and patients with diabetes to use an eHealth tool supporting the annual foot examination?
3. Interviews - to use a paper format supporting a structured foot assessment

a. How do health care professionals experience to use a structured foot form, in paper form?
4. Interviews - footwear

a. What factors that influence how patients with diabetes choose their footwear?
5. Interviews - usability test of using an eHealth tool

a. How could a digital eHealth tool be designed? b. How could a digital eHealth solution be implemented, managed and spread in public health care setting? i. Participants will:

1\. fill in questionnaires 2. be interviewed 3. test eHealth solutions supporting the foot examination

6\. Experiences of using an eHealth tool supporting the foot assessment

a. How could a digital eHealth tool be designed?

7\. Questionnaires regarding self-perceived quality of life, the experiences of the visit at the care unit, transportation to the care unit.

a. Patients that visits care fills in a questionnaire regarding self-perceived quality of life (EQ-5D), a modified version of National Patient Survey, the diabetes questionnaire and a questionnaire regarding their travels and time for travels to and from the visit to the care unit.

8\. Critical evaluation of complexity

1. Exists complexity in the development, test, management, spread and sustain of an eHealth tool supporting foot examination and self-care of the feet in diabetes.
2. How could a digital eHealth solution be implemented, managed and spread in public health care setting?

9\. Long term effect

a. What is the long-term effect of using an eHealth tools supporting a structured foot examination?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria patients: * Persons with diabetes being treated in Region Västra Götaland * Understand spoken and written Swedish Exclusion Criteria: • Not understand spoken and written Swedish Inclusion Criteria healthcare professionals: * Professionals working with patients with diabetes having foot complications. * Working in Region Västra Götaland * Understand spoken and written Swedish

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Departmetn of Prosthetics & Orthotics, Sahlgrenska University Hospital Gothenburg Sweden Recruiting

More Sahlgrenska University Hospital trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05692778 on ClinicalTrials.gov ↗ ← All trials in Sweden